Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 157 M
0,05 %0,09 %32.55x6.18x8.04x24.82x25.28x 55,2 Md
1,52 %1,73 %20.93x4.04x6.45x14.11x16.37x 55,6 Md
-.--%-.--%-18.58x1.14x4.52x-7.92x-6.68x 23,51 Md
-.--%-.--%-40.37x52.12x12.81x-37.74x-41.41x 22,35 Md
-.--%-.--%25.93x2.53x5.08x13.45x16.08x 20,6 Md
-.--%-.--%24.39x2.77x4.74x15.42x17.39x 17,45 Md
-.--%-.--%-762.09x18.77x36.16x-4070.99x-511.57x 15,16 Md
-.--%-.--%17.41x4.95x5.04x11.76x13.01x 13,91 Md
0,09 %0,14 %41.47x10.64x16.7x43.01x39.45x 13,74 Md
-.--%-.--%-77.71x28.99x8.05x-64.17x-59.52x 12,61 Md
-.--%-.--%-26.76x28.66x25.26x-31.9x-25.68x 12,14 Md
-.--%0,03 %-5173.8x7.97x14.02x93.49x416.33x 11,23 Md
-.--%-.--%-12.26x-85.16x89.09x-13.89x-13.5x 10,64 Md
-.--%-.--%-10.68x38.08x2381.1x-12.62x-10.97x 10,21 Md
-.--%-.--%-31.85x8.75x - -29.42x-28.46x 8,61 Md
-.--%-.--%11.79x5.79x7.57x11.61x11.25x 8,37 Md
Moyenne 0,1 % 0,12 % -373,73x 8,52x 174,98x -252,56x -8,91x 18,32 Md
Moyenne pondérée par Capi. 0,28 % 0,33 % -218,42x 8,89x 92,89x -192,36x -6,33x
Médicaments bio-thérapeutiques
🔇